Raymond Mwebaze

Author PubWeight™ 12.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.	Lancet	2002	5.80
2	Assessment of second-line antiretroviral regimens for HIV therapy in Africa.	N Engl J Med	2014	2.00
3	Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.	J Acquir Immune Defic Syndr	2005	1.59
4	Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients.	AIDS Res Hum Retroviruses	2002	1.11
5	Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country.	J Diabetes Metab Disord	2014	0.98
6	Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.	AIDS	2003	0.93
7	Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified?	J Diabetes Metab Disord	2013	0.88
8	Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial.	J Acquir Immune Defic Syndr	2016	0.75